Article Details

Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Brokerages

Retrieved on: 2021-06-26 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Brokerages. View article details on hiswai:

Excerpt

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its position ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo